ask="1.35"
ask_size="600"
average_daily_volume="861710"
bid="1.20"
bid_size="400"
book_value="1.37"
change="+0.02"
change_from_200_day_moving_average="-1.35"
change_from_50_day_moving_average="-0.32"
change_from_52_week_high="-7.75"
change_From_52_week_low="0.21"
change_in_percent="+2.22%"
close="1.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.27"
eps_estimate_next_quarter="-0.35"
eps_estimate_next_year="-1.07"
ex_dividend_date="N/A"
float_shares="36930000"
high="1.25"
high_52_weeks="8.90"
last_trade_date="3/7/2017"
last_trade_price="1.15"
last_trade_size="200"
last_trade_time="3:59pm"
low="1.05"
low_52_weeks="0.94"
market_capitalization="60.86M"
moving_average_200_day="2.50"
moving_average_50_day="1.47"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="5.80"
open="1.10"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-54.07%"
percent_change_from_50_day_moving_average="-21.81%"
percent_change_from_52_week_high="-87.08%"
percent_change_from_52_week_low="+22.34%"
previous_close="1.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.82"
price_per_sales="4.95"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="3.47"
stock_exchange="NGM"
symbol="RGLS"
volume="1038232"
weeks_range_52="0.94 - 8.90"
